Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Sex-linked Disorders

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag.

NEJM evidence·2026

Same author

Umbilical cord blood transplantation in children with Diamond-Blackfan anemia.

Bone marrow transplantation·2026

Same author

HLH and spinal neurofibroma: a single case report in a patient with DiGeorge syndrome.

Frontiers in oncology·2026

Same author

American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic Anemia.

Blood advances·2026

Same author

Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High-Risk Neuroblastoma: A Large Single-Center Experience.

Pediatric blood & cancer·2026

Same author

A Computational Approach to Evaluating Empirical Antibiotic Coverage for Gram-Negative Bloodstream Infections in Pediatric Febrile Neutropenia.

Antibiotics (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: May 27, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Fanconi anemia - learning from children.

Johanna Svahn¹, Carlo Dufour

¹Department of Pediatrie Hematology Oncology and Bone Marrow Transplantation, Caslini Childrens Hospital, Gsenova, Italy.

Pediatric Reports

|November 5, 2011

Summary

Fanconi Anemia (FA) is a rare genetic disorder causing bone marrow failure and increased cancer risk. This paper reviews treatments for bone marrow failure in FA patients.

Area of Science:

Genetics
Hematology
Oncology

Background:

Fanconi Anemia (FA) is a rare genetic disorder characterized by chromosomal instability.
Clinical manifestations include somatic malformations, bone marrow failure, and cancer predisposition.
Progressive pancytopenia is a common early sign, but acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) can also occur.

Purpose of the Study:

This paper focuses on the treatment of bone marrow failure in patients with Fanconi Anemia.
To provide an overview of current therapeutic strategies for managing bone marrow failure in FA.

Main Methods:

Literature review of studies on Fanconi Anemia treatment.
Analysis of clinical data regarding bone marrow failure management.

Keywords:

Fanconi anemia.

More Related Videos

Measuring the Confluence of iPSCs Using an Automated Imaging System

Measuring the Confluence of iPSCs Using an Automated Imaging System

Published on: June 10, 2020

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Related Experiment Videos

Last Updated: May 27, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Measuring the Confluence of iPSCs Using an Automated Imaging System

Measuring the Confluence of iPSCs Using an Automated Imaging System

Published on: June 10, 2020

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Main Results:

Bone marrow failure, particularly pancytopenia, is a primary cause of morbidity and mortality in FA.
Squamous cell carcinoma (SCC) of the head, neck, and other sites occurs with high frequency in FA patients.
Treatment strategies aim to address bone marrow failure and associated complications.

Conclusions:

Effective management of bone marrow failure is crucial for improving outcomes in Fanconi Anemia.
Early diagnosis and intervention are essential for managing FA complications.
Further research into novel treatment modalities is warranted.